Suchergebnisse - "Sharma, Jyoti"

PubPharm (8)

1

A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors

enthalten in: Investigational new drugs | 2018

von Mehnert, J. | Edelman, G. | Stein, M. | +7

2

A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors

enthalten in: Investigational new drugs | 2017

von Mehnert, J. | Edelman, G. | Stein, M. | +7

3

A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors

enthalten in: Investigational new drugs | 2017

von Mehnert, J. | Edelman, G. | Stein, M. | +7

4

A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors

enthalten in: Investigational new drugs | 2017

von Mehnert, J. | Edelman, G. | Stein, M. | +7

5

Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Bechter, O. | Dumez, H. | Costermans, J. | +8

6

Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Bechter, O. | Dumez, H. | Costermans, J. | +8

7

Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Bechter, O. | Dumez, H. | Costermans, J. | +8

8

Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Bechter, O. | Dumez, H. | Costermans, J. | +8

1
[1]